At a glance
- Originator Pharmacia Corporation
- Class Anti-inflammatories; Antiasthmatics
- Mechanism of Action Lipid peroxidation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Asthma in USA (Unknown route)